Evidence map›Paper›PMID 32293354›Full record

ArticleBMC cancer2020

Gastrointestinal peptides in children before and after hematopoietic stem cell transplantation.

Szymon Skoczeń, Magdalena Rej, Kinga Kwiecińska, Danuta Pietrys, Przemysław J Tomasik, Małgorzata Wójcik, Wojciech Strojny, Agnieszka Dłużniewska, Katarzyna Klimasz, Kamil Fijorek and 3 more

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 4 institutions in 1 country.

Szymon SkoczeńDepartment of Oncology and Hematology, University Children's Hospital in Krakow, Jagiellonian University Medical College, Wielicka St. 265, 30-663, Krakow, Poland.
Magdalena RejDepartment of Oncology and Hematology, University Children's Hospital in Krakow, Jagiellonian University Medical College, Wielicka St. 265, 30-663, Krakow, Poland. rej.magdalena@gmail.com.
Kinga KwiecińskaDepartment of Oncology and Hematology, University Children's Hospital in Krakow, Jagiellonian University Medical College, Wielicka St. 265, 30-663, Krakow, Poland.
Danuta PietrysDepartment of Oncology and Hematology, University Children's Hospital in Krakow, Wielicka St. 265, 30-663, Krakow, Poland.
Przemysław J TomasikDepartment of Clinical Biochemistry, University Children's Hospital in Krakow, Jagiellonian University Medical College, Wielicka St. 265, 30-663, Krakow, Poland.
Małgorzata WójcikDepartment of Pediatric and Adolescent Endocrinology, University Children's Hospital in Krakow, Jagiellonian University Medical College, Wielicka St. 265, 30-663, Krakow, Poland.
Wojciech StrojnyDepartment of Oncology and Hematology, University Children's Hospital in Krakow, Wielicka St. 265, 30-663, Krakow, Poland.
Agnieszka DłużniewskaStem Cell Transplantation Center, University Children's Hospital in Krakow, Wielicka St. 265, 30-663, Krakow, Poland.
Katarzyna KlimaszDepartment of Biochemistry, University Children's Hospital in Krakow, Wielicka St. 265, 30-663, Krakow, Poland.
Kamil FijorekDepartment of Statistics, Cracow University of Economics, 27 Rakowicka Str., 31-510, Krakow, Poland.
Michał KorostyńskiDepartment of Molecular Neuropharmacology, Institute of Pharmacology of Polish Academy of Sciences, 12 Smętna St., 31-343, Krakow, Poland.
Marcin PiechotaDepartment of Molecular Neuropharmacology, Institute of Pharmacology of Polish Academy of Sciences, 12 Smętna St., 31-343, Krakow, Poland.
Walentyna BalwierzDepartment of Oncology and Hematology, University Children's Hospital in Krakow, Jagiellonian University Medical College, Wielicka St. 265, 30-663, Krakow, Poland.
Uniwersytecki Szpital Dziecięcy · PLJagiellonian University · PLPolish Academy of Sciences · PLKrakow University of Economics · PL

Funding

Narodowe Centrum Nauki NN 407 198737
6 · The paper itself

Abstract

backgroundGastrointestinal tract function and it's integrity are controlled by a number of peptides whose secretion is influenced by severe inflammation. In stomach the main regulatory peptide is ghrelin. For upper small intestine cholecystokinin and lower small intestine glucagon-like peptide- 1 are secreted, while fibroblast growth factor-21 is secreted by several organs, including the liver, pancreas, and adipose tissue [12]. Hematopoietic stem cell transplantation causes serious mucosal damage, which can reflect on this peptides.

methodsThe aim of the study was to determine fasting plasma concentrations of ghrelin, cholecystokinin, glucagon- like peptide-1, and fibroblast growth factor-21, and their gene expressions, before and 6 months after hematopoietic stem cell transplantation.27 children were studied, control group included 26 healthy children.

resultsAcute graft versus host disease was diagnosed in 11 patients (41%, n = 27). Median pre-transplantation concentrations of gastrointestinal peptides, as well as their gene expressions, were significantly lower in studied group compared with the control group. Only median of fibroblast growth factor-21 concentration was near-significantly higher before stem cell transplantation than in the control group. The post-hematopoietic transplant results revealed significantly higher concentrations of the studied peptides (except fibroblast growth factor-21) and respective gene expressions as compare to pre transplant results. Median glucagone like peptide-1 concentrations were significantly decreased in patients with features of acute graft versus host disease. Moreover, negative correlation between glucagone like peptide-1 concentrations and acute graft versus host disease severity was found.

conclusionsIncreased concentrations and gene expressions of gastrointestinal tract regulation peptides can be caused by stimulation of regeneration in the severe injured organ. Measurement of these parameters may be a useful method of assessment of severity of gastrointestinal tract complications of hematopoietic stem cell transplantation.

Indexed as

AdolescentCase-Control StudiesChildChild, PreschoolCholecystokininFemaleFibroblast Growth FactorsGene Expression Regulation, NeoplasticGhrelinGlucagon-Like Peptide 1Graft vs Host DiseaseHematopoietic Stem Cell TransplantationHumansInfantMaleNeoplasmsCholecystokininFGF21 protein, humanFibroblast Growth FactorsGhrelinGlucagon-Like Peptide 1ChildrenHematopoietic stem cell transplantationPeptides regulating gastrointestinal tract functions

Identifiers

PMID32293354
PMCPMC7161205
OpenAlexW3015324284

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.